Who owns Amylin Pharmaceuticals?

Key details on Amylin Pharmaceuticals (Ticker: AMLN)

Who owns Amylin Pharmaceuticals?

Is AMLN a good stock to own? Find out who bought Amylin Pharmaceuticals, who sold Amylin Pharmaceuticals (AMLN) stock, and who holds a large position in Amylin Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Wellington Management Company 22.48M $634.75M June 30, 2012
CARL C. ICAHN, INDIVIDUAL 14.38M $163.67M Dec. 31, 2011
Vanguard 7.74M $193.31M March 31, 2012
T. Rowe Price Associates 7.02M $198.17M June 30, 2012
OppenheimerFunds 6.89M $194.38M June 30, 2012
Adage Capital Partners GP 5.76M $162.66M June 30, 2012
OZ Management 4.88M $137.62M June 30, 2012
Barclays 3.67M $91.55M March 31, 2012
Pentwater Capital Management 3.22M $90.80M June 30, 2012
Millennium Management 2.81M $32.00M Dec. 31, 2011
STATE STREET CORPORATION 2.66M $66.48M March 31, 2012
HealthCor Management 2.65M $66.14M March 31, 2012
CALAMOS ADVISORS 2.40M $59.90M March 31, 2012
GOLDMAN SACHS 2.24M $63.27M June 30, 2012
BB Biotech AG 2.17M $61.29M June 30, 2012
S.A.C. Capital Advisors 2.13M $24.28M Dec. 31, 2011
Tang Capital Management 1.99M $56.13M June 30, 2012
Rainier Investment Management 1.71M $42.68M March 31, 2012
Deerfield Management Company 1.63M $40.68M March 31, 2012
York Capital Management Global Advisors 1.60M $45.07M June 30, 2012
Scopia Management 1.60M $45.03M June 30, 2012
Chesapeake Partners Management 1.58M $44.61M June 30, 2012
RCM Capital Management 1.54M $38.55M March 31, 2012
Eton Park Capital Management 1.23M $34.62M June 30, 2012
PointState Capital 1.23M $34.55M June 30, 2012
Renaissance Technologies 1.13M $28.19M March 31, 2012
Sector Gamma ASA 1.10M $27.45M March 31, 2012
Citi 1.04M $11.90M Dec. 31, 2011
First Trust Advisors 956490 $26.97M June 30, 2012
UBS AG 940033 $26.51M June 30, 2012
Bank of America Corporation 931900 $26.28M June 30, 2012
Empyrean Capital Partners 900000 $25.38M June 30, 2012
D. E. Shaw & Co 843038 $23.80M June 30, 2012
QS Investors 723400 $20.42M June 30, 2012
Giovine Capital 720000 $20.30M June 30, 2012
Jet Capital Investors 653100 $18.42M June 30, 2012
Jacobs Levy Equity Management 648887 $7.38M Dec. 31, 2011
Redmile 625000 $7.11M Dec. 31, 2011
Kingdon Capital Management 612000 $15.27M March 31, 2012
Inves 606282 $6.90M Dec. 31, 2011
SMITH ASSET MANAGEMENT 548695 $6.24B Dec. 31, 2011
Perella Weinberg Partners Capital Management 536400 $13.39M March 31, 2012
Denver Investment Advisors 523909 $5.96M Dec. 31, 2011
Davidson Kempner Capital Management 519135 $14.64M June 30, 2012
Platte River Capital 516078 $5.87M Dec. 31, 2011
Jefferies 506512 $14.28M June 30, 2012

Who sold Amylin Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management June 30, 2012 510029 $15.70M
Partner Fund Management Sept. 30, 2011 3.04M $28.04M
Westfield Capital Management Company Sept. 30, 2011 1.85M $17.06M
Partner Investment Management Sept. 30, 2011 1.63M $15.04M
TIAA-CREF Investment Management Sept. 30, 2011 639209 $5.90M
Bridger Management June 30, 2011 813000 $10.86M
Alyeska Investment March 31, 2011 3.00M $34.11M
FMR Dec. 31, 2010 21.58M $317.51M
Brookside Capital Management, LLC* Dec. 31, 2010 3.21M $47.22M
BAM Capital Dec. 31, 2010 789584 $11.61M
Columbia Wanger Asset Management Sept. 30, 2010 1.97M $40.94M
Tudor Investment Corporation Dec. 31, 2008 1.48M $16.09M
Maverick Capital June 30, 2008 2.58M $65.43M
Navellier & Associates Dec. 31, 2002 1.95M $31.46M